evolocumab 420 in 3.5 ML Cartridge

RxCUI: 1801319
RxNorm name: evolocumab 420 in 3.5 ML Cartridge
Display name: evolocumab 420 in 3.5 ML Cartridge
Full name: evolocumab 420 in 3.5 ML Cartridge
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:21

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125522	Repatha	evolocumab	351(a)	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
REPATHA	EVOLOCUMAB	Amgen USA Inc.	cd61e902-166d-4aa6-9f3c-a18c1008d07e	2026-07-16	Warnings, Adverse reactions	Exact identifier rxcui: 1801319

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
cd61e902-166d-4aa6-9f3c-a18c1008d07e	evolocumab 420 in 3.5 ML Cartridge	PSN	27	These highlights do not include all the information needed to use REPATHA ® safely and effectively. See full prescribing information for REPATHA. REPATHA (evolocumab) injection, for subcutaneous use Initial U.S. Approval: 2015	20260122
cd61e902-166d-4aa6-9f3c-a18c1008d07e	evolocumab 420 per 3.5 ML Cartridge	SY	27	These highlights do not include all the information needed to use REPATHA ® safely and effectively. See full prescribing information for REPATHA. REPATHA (evolocumab) injection, for subcutaneous use Initial U.S. Approval: 2015	20260122
cd61e902-166d-4aa6-9f3c-a18c1008d07e	3.5 ML evolocumab 120 MG/ML Cartridge	SCD	27	These highlights do not include all the information needed to use REPATHA ® safely and effectively. See full prescribing information for REPATHA. REPATHA (evolocumab) injection, for subcutaneous use Initial U.S. Approval: 2015	20260122